CVS Health: BofA Global Research cuts price objective to $110 from $120
CVS•BofA Global Research cut its price objective for CVS Health to $110 from $120.
Related News
AECOM-led JV wins Ontario Highway 413 program management contract
ACM•
Viking Therapeutics launches oral maintenance dosing trial of obesity drug VK2735
VKTX•
Coatings maker RPM International Q1 profit beats on organic growth, pricing
RPM•
Agility Robotics to livestream analyst, investor day as Churchill Capital XI deal nears close
CCXI•
PENN Entertainment raised to buy from hold by Deutsche Bank; target price raised to $25 from $23
PENN•